ANIX - Anixa Biosciences, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
10/30/2018
10/30/2017
10/30/2016
10/30/2015
Total Revenue
250
1,113
363
300
9,255
Cost of Revenue
167
768
105
217
3,649
Gross Profit
83
344
258
83
5,606
Operating Expenses
Research Development
7,035
6,813
1,598
1,556
-
Selling General and Administrative
6,715
6,912
4,411
2,710
6,226
Total Operating Expenses
14,250
14,050
6,334
4,592
6,551
Operating Income or Loss
-14,167
-13,706
-6,076
-4,509
-945
Interest Expense
-
0
500
520
452
Total Other Income/Expenses Net
-
-583
1,548
-106
-3,501
Income Before Tax
-15,099
-14,243
-5,009
-5,016
-1,379
Income Tax Expense
0
0
0
0
0
Income from Continuing Operations
-15,099
-14,243
-5,009
-5,016
-1,379
Net Income
-14,862
-13,996
-5,009
-5,016
-1,379
Net Income available to common shareholders
-14,862
-13,996
-7,018
-5,016
-1,379
Reported EPS
Basic
-
-0.79
-0.58
-0.52
-0.15
Diluted
-
-0.79
-0.58
-0.52
-0.15
Weighted average shares outstanding
Basic
-
17,624
12,197
9,602
9,625
Diluted
-
17,624
12,197
9,602
9,625
EBITDA
-
-13,899
-4,140
-4,138
-602